Veerhealth Care Ltd.
BSE: 511523 | Sector: Health care |
NSE: NIYATILEAS | ISIN Code: INE882C01035 |
BSE 00:00 | 16 May | 12.25 |
0 (0.00%) |
OPEN
12.25 |
HIGH
12.25 |
LOW
12.25 |
NSE 05:30 | 01 Jan | Veerhealth Care Ltd |
OPEN | 12.25 |
PREVIOUS CLOSE | 12.25 |
VOLUME | 600 |
52-Week high | 18.98 |
52-Week low | 8.20 |
P/E | 175.00 |
Mkt Cap.(Rs cr) | 8 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Veerhealth Care Ltd. (NIYATILEAS) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Aurobindo Pharma | 550.75 | -11.40 | -2.03 | 15823.68 |
Cipla | 933.10 | 0.25 | 0.03 | 13900.58 |
Dr Reddy's Labs | 3887.25 | -36.25 | -0.92 | 13349.10 |
Sun Pharma.Inds. | 885.75 | 3.65 | 0.41 | 12803.21 |
Lupin | 684.65 | -11.65 | -1.67 | 11055.93 |
Apollo Hospitals | 3688.20 | 140.00 | 3.95 | 9153.00 |
Zydus Lifesci. | 345.15 | 4.45 | 1.31 | 7790.40 |
Glenmark Pharma. | 392.50 | -1.55 | -0.39 | 7567.93 |
Alkem Lab | 2901.90 | -1.10 | -0.04 | 7219.68 |
Divi's Lab. | 4219.55 | -64.20 | -1.50 | 6798.61 |
Torrent Pharma. | 2584.45 | 3.10 | 0.12 | 6450.83 |
Ipca Labs. | 983.90 | 8.95 | 0.92 | 5114.11 |
Alembic Pharma | 739.90 | -1.55 | -0.21 | 5051.44 |
Laurus Labs | 542.30 | 3.85 | 0.72 | 4768.72 |
Abbott India | 16529.20 | -13.20 | -0.08 | 4310.02 |
Gland Pharma | 3109.65 | 114.25 | 3.81 | 3462.88 |
Glaxosmi. Pharma | 1514.10 | 22.45 | 1.51 | 3193.74 |
Granules India | 242.15 | 2.90 | 1.21 | 3134.98 |
Sanofi India | 6607.10 | -141.40 | -2.10 | 2956.60 |
Ajanta Pharma | 1683.60 | -27.45 | -1.60 | 2718.59 |
Quick Links for Veerhealth Care:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices